Drug
Quetiapine Fumarate Extended Release
Quetiapine Fumarate Extended Release: highest development phase Phase 3, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| Quetiapine Fumarate Extended- Release NCT00640601 | Phase 3 | Schizophrenia |
Latest
No recent events.
Follow Quetiapine Fumarate Extended Release on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.